The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.105553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Keren He und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Biological Products, Neoplasms, Carcinogenesis, Hexokinase. Die Arbeit wurde bisher 32-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
- School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
- Zhejiang Key Laboratory of Blood-Stasis-Toxin Syndrome, Zhejiang Chinese Medical University, Hangzhou, China.
Zitieren
APA
He, K., Tao, F., Lu, Y., Fang, M., Huang, H., & Zhou, Y. (2025). The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.105553
Vancouver
He K, Tao F, Lu Y, Fang M, Huang H, Zhou Y. The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.105553
BibTeX
@article{He2025,
author = {He, Keren and Tao, Fangfang and Lu, Yangyuxiao and Fang, Mengqi and Huang, Hong and Zhou, Yuan},
title = {The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.105553}
}
EUVIMED